Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Journal of Pharmacological Sciences
|
January 21, 2024
CU06-1004 alleviates oxidative stress and inflammation on folic acid-induced acute kidney injury in mice
Cho-Rong Bae, Yeomyeong Kim, Young-Guen Kwon
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Basic Science and Pathogenesis
Young-Guen Kwon, Cho-Rong Bae, Yeomyeong Kim, et al.
European Journal of Pharmacology
|
December 12, 2022
Oral administration of CU06-1004 attenuates vascular permeability and stabilizes neovascularization in retinal vascular diseases
Minyoung Noh, Yeomyeong Kim, Haiying Zhang, et al.
Allergy
|
February 15, 2023
CU06-1004 alleviates vascular hyperpermeability in a murine model of hereditary angioedema by protecting the endothelium
Sunghye Lee, Yeomyeong Kim, Ye-Seul Kim, et al.
Fluids and Barriers of the CNS
|
February 2, 2023
Long-term administration of CU06-1004 ameliorates cerebrovascular aging and BBB injury in aging mouse model
Hyejeong Kim, Minyoung Noh, Haiying Zhang, et al.
Experimental & Molecular Medicine
|
November 15, 2019
MicroRNA-148a/b-3p regulates angiogenesis by targeting neuropilin-1 in endothelial cells
Hyejeong Kim, Yeongrim Ko, Hyojin Park, et al.
Frontiers in Pharmacology
|
November 7, 2025
CU06-1004 inhibits the progression of chronic colitis and colitis-associated colorectal cancer by suppressing inflammation
Dongyeop Kim, Yeomyeong Kim, Haiying Zhang, et al.
Journal of Neuroinflammation
|
February 6, 2020
CLEC14A deficiency exacerbates neuronal loss by increasing blood-brain barrier permeability and inflammation
Yeomyeong Kim, Sungwoon Lee, Haiying Zhang, et al.
Journal of Inflammation (London, England)
|
April 6, 2023
Efficacy of CU06-1004 via regulation of inflammation and endothelial permeability in LPS-induced acute lung injury
Yeomyeong Kim, Cho-Rong Bae, Dongyeop Kim, et al.
Frontiers in Pharmacology
|
November 30, 2023
A novel small molecule, CU05-1189, targeting the pleckstrin homology domain of PDK1 suppresses VEGF-mediated angiogenesis and tumor growth by blocking the Akt signaling pathway
Jeongeun Park, Haiying Zhang, Hyun Jung Kwak, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Journal of Pharmacological Sciences
|
January 21, 2024
CU06-1004 alleviates oxidative stress and inflammation on folic acid-induced acute kidney injury in mice
Cho-Rong Bae, Yeomyeong Kim, Young-Guen Kwon
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Basic Science and Pathogenesis
Young-Guen Kwon, Cho-Rong Bae, Yeomyeong Kim, et al.
European Journal of Pharmacology
|
December 12, 2022
Oral administration of CU06-1004 attenuates vascular permeability and stabilizes neovascularization in retinal vascular diseases
Minyoung Noh, Yeomyeong Kim, Haiying Zhang, et al.
Allergy
|
February 15, 2023
CU06-1004 alleviates vascular hyperpermeability in a murine model of hereditary angioedema by protecting the endothelium
Sunghye Lee, Yeomyeong Kim, Ye-Seul Kim, et al.
Fluids and Barriers of the CNS
|
February 2, 2023
Long-term administration of CU06-1004 ameliorates cerebrovascular aging and BBB injury in aging mouse model
Hyejeong Kim, Minyoung Noh, Haiying Zhang, et al.
Experimental & Molecular Medicine
|
November 15, 2019
MicroRNA-148a/b-3p regulates angiogenesis by targeting neuropilin-1 in endothelial cells
Hyejeong Kim, Yeongrim Ko, Hyojin Park, et al.
Frontiers in Pharmacology
|
November 7, 2025
CU06-1004 inhibits the progression of chronic colitis and colitis-associated colorectal cancer by suppressing inflammation
Dongyeop Kim, Yeomyeong Kim, Haiying Zhang, et al.
Journal of Neuroinflammation
|
February 6, 2020
CLEC14A deficiency exacerbates neuronal loss by increasing blood-brain barrier permeability and inflammation
Yeomyeong Kim, Sungwoon Lee, Haiying Zhang, et al.
Journal of Inflammation (London, England)
|
April 6, 2023
Efficacy of CU06-1004 via regulation of inflammation and endothelial permeability in LPS-induced acute lung injury
Yeomyeong Kim, Cho-Rong Bae, Dongyeop Kim, et al.
Frontiers in Pharmacology
|
November 30, 2023
A novel small molecule, CU05-1189, targeting the pleckstrin homology domain of PDK1 suppresses VEGF-mediated angiogenesis and tumor growth by blocking the Akt signaling pathway
Jeongeun Park, Haiying Zhang, Hyun Jung Kwak, et al.
Page
of 2